Electrophysiological Imaging for Ventricular Tachycardia
Peri-Procedural Transmural Electrophysiological (EP) Imaging of Scar-Related Ventricular Tachycardia
Recruiting
N/AInterventional Study
Ventricular TachycardiaMyocardial Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
20 (estimated)
Sponsor
John Sapp · Other
Who this trial is looking for
This trial is looking for patients who have experienced episodes of a fast heart rhythm called ventricular tachycardia (VT) and are considering a procedure to treat it. Participants will undergo imaging to help guide their treatment and improve outcomes.
Are You a Good Fit for This Trial?
You may be able to join if
I have had one or more episodes of ventricular tachycardia.
I am referred for a catheter ablation procedure.
I have a previously implanted ICD.
I can sign the patient consent form.
I am willing to comply with all required testing.
You may not be able to join if
I have an estimated kidney function (eGFR) less than 30.
I have a life expectancy of less than 6 months.
I am pregnant.
I am on IV inotropic agents.
I have any issues that prevent catheter ablation.
I am in New York Heart Association functional class IV.
I had a heart attack within the last month.
I am unable or unwilling to undergo cardiac MRI or CT scan.
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Ventricular tachycardia (VT) contributes to over 350,000 sudden deaths each year in the US. Malignant VTs involve an electrical "short circuit" in the heart, formed by narrow channels of surviving tissue inside myocardial scar. An important treatment is to use catheter ablation to "block" the channel that forms the circuit. Effective ablation requires imaging guidance to visualize the VT circuit r…
Ventricular tachycardia (VT) contributes to over 350,000 sudden deaths each year in the US. Malignant VTs involve an electrical "short circuit" in the heart, formed by narrow channels of surviving tissue inside myocardial scar. An important treatment is to use catheter ablation to "block" the channel that forms the circuit. Effective ablation requires imaging guidance to visualize the VT circuit relative to scar structures in 3D. Unfortunately, with conventional catheter mapping, up to 90% of the VT circuits are too short-lived to be mapped. For the 10% "mappable" VTs, their data are only available during ablation and limited to one ventricular surface. This inadequacy of functional VT data largely limits the knowledge about scar-related VT and ablation strategies, and reduces the ability of clinicians to identify ablation targets and assess ablation outcome.
The central hypothesis of this proposal is that functional VT data, integrated with CT or MRI scar data in 3D, can improve VT ablation efficacy with pre-procedural identification of ablation targets and post-procedural mechanistic elucidation of ablation failure. This research builds on the rapidly increasing clinical interest in electrocardiographic imaging (ECGi), an emerging technique that obtains cardiac electrical activity through inverse reconstructions from ECGs. The specific objective is to push the boundary of ECGi to provide - as a conjunction to intra-procedural catheter mapping - pre-ablation and post-ablation imaging of functional VT circuits integrated with 3D scar structure.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* One or more episodes of sustained monomorphic VT
* Referred for catheter ablation
* Previously implanted ICD
* Signed the patient informed consent form
* Able and willing to comply with all pre-, post-, and follow-up testing and requirements
Exclusion Criteria:
* Have estima…
Inclusion Criteria:
* One or more episodes of sustained monomorphic VT
* Referred for catheter ablation
* Previously implanted ICD
* Signed the patient informed consent form
* Able and willing to comply with all pre-, post-, and follow-up testing and requirements
Exclusion Criteria:
* Have estimated Glomerular Filtration Ratio (eGFR) less than 30
* Have a life expectancy less than 6 months or are listed for heart transplantation at time of inclusion
* Are pregnant
* Are on IV inotropic agents
* Have any contraindication to catheter ablation (including but not limited to mechanical prosthetic aortic and mitral valves, known protruding Left Ventricular (LV) thrombus
* New York Heart Association (NYHA) functional class IV
* Had ST wave elevation myocardial infarction within \< 1 month
* Unwilling or unable to undergo cardiac MRI scan AND unwilling or unable to undergo cardiac CT scan (e.g. contrast allergy).
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.